Evidence map›Paper›PMID 33033981›Full record

ArticleJournal of physiology and biochemistry2020

Loss of the nutrient receptor Tas1R3 reduces atherosclerotic plaque accumulation and hepatic steatosis in ApoE

Shayla S Shojaat, Samuel Engman, Jason Hofferber, Faithe Keomanivong, Eric M Wauson

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of physiology and biochemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Shayla S ShojaatDepartment of Physiology and Pharmacology, College of Osteopathic Medicine, Des Moines University, 3200 Grand Avenue, Des Moines, IA, 50312, USA.
Samuel EngmanDepartment of Physiology and Pharmacology, College of Osteopathic Medicine, Des Moines University, 3200 Grand Avenue, Des Moines, IA, 50312, USA.
Jason HofferberDepartment of Physiology and Pharmacology, College of Osteopathic Medicine, Des Moines University, 3200 Grand Avenue, Des Moines, IA, 50312, USA.
Faithe KeomanivongDepartment of Physiology and Pharmacology, College of Osteopathic Medicine, Des Moines University, 3200 Grand Avenue, Des Moines, IA, 50312, USA.
Eric M WausonDepartment of Physiology and Pharmacology, College of Osteopathic Medicine, Des Moines University, 3200 Grand Avenue, Des Moines, IA, 50312, USA. eric.wauson@dmu.edu.ORCID http://orcid.org/0000-0002-6736-9000
Des Moines University · US

Funding

American Heart Association 15SDG25090279Iowa Osteopathic Education and Research Foundation -
6 · The paper itself

Abstract

The taste receptor type I (Tas1R) family consists of three G protein-coupled receptors (T1R1, T1R2, and T1R3) that form heterodimers recognizing sweet compounds (T1R2/T1R3) or amino acids (T1R1/T1R3). These receptors are nutrient sensors that facilitate appropriate physiological responses with nutrient availability. However, their contribution to the development of pathologies associated with overnutrition (e.g., atherosclerosis) is unclear. The aim of the present study was to determine if T1R3 deletion would reduce atherosclerotic plaque development in mice. We generated atherosclerotic mice with whole-body deletion of T1R3 by crossing T1R3

Indexed as

Plaque, AtheroscleroticAnimalsAtherosclerosisFatty LiverFemaleLiverMaleMiceMice, Knockout, ApoEReceptors, G-Protein-CoupledTriglyceridesReceptors, G-Protein-Coupledtaste receptors, type 1TriglyceridesApoEAtherosclerosisHepatic steatosisHyperinsulinemiamTORC1T1R1T1R2T1R3Tas1R1Tas1R2Tas1R3Taste receptor

Identifiers

PMID33033981
OpenAlexW3091779411

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.